Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0770
D

Failure to Obtain Ordered Keppra Level for Resident on Anticonvulsant Therapy

Savoy, Texas Survey Completed on 05-29-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that laboratory services were obtained as ordered for a resident with a seizure disorder who was receiving Keppra, an anticonvulsant medication. The resident's care plan and hospice admission orders specified that routine labs were to be discontinued except for the Keppra level, which was to be monitored every three months. Despite these orders, the Keppra level was not obtained for the month of May. Record review showed that the last Keppra level was within therapeutic range in February, and the resident continued to receive Keppra as prescribed. However, a lab requisition to discontinue routine labs did not specify that the Keppra level should continue, leading to the cancellation of all labs, including the required Keppra level. Interviews with facility staff and the lab company revealed a miscommunication regarding which labs were to be discontinued, resulting in the Keppra level not being drawn as ordered. The Director of Nursing (DON) acknowledged that the omission occurred when the lab requisition was filled out and that nursing staff were responsible for ensuring labs were obtained as ordered. The lab company also indicated that both the facility and the lab were responsible for ensuring the correct labs were drawn, and the failure to do so was due to a lack of clarification and follow-up. There was no policy in place at the facility regarding laboratory services.

An unhandled error has occurred. Reload 🗙